Jean‐François Viallard

10.3k total citations
171 papers, 3.8k citations indexed

About

Jean‐François Viallard is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Jean‐François Viallard has authored 171 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Hematology, 57 papers in Immunology and 38 papers in Genetics. Recurrent topics in Jean‐François Viallard's work include Platelet Disorders and Treatments (58 papers), Immunodeficiency and Autoimmune Disorders (42 papers) and Blood groups and transfusion (32 papers). Jean‐François Viallard is often cited by papers focused on Platelet Disorders and Treatments (58 papers), Immunodeficiency and Autoimmune Disorders (42 papers) and Blood groups and transfusion (32 papers). Jean‐François Viallard collaborates with scholars based in France, United States and United Kingdom. Jean‐François Viallard's co-authors include Jean‐Luc Pellegrin, Jean‐François Moreau, Patrick Blanco, Bertrand Godeau, B Leng, Felipe Suárez, Adrian C. Newland, Estibaliz Lazaro, Claire Fieschi and Alan T. Nurden and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Jean‐François Viallard

159 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean‐François Viallard France 31 1.8k 1.3k 634 595 510 171 3.8k
Roshini S. Abraham United States 32 1.7k 0.9× 1.2k 0.9× 427 0.7× 660 1.1× 551 1.1× 126 4.4k
Siraj Misbah United Kingdom 30 1.3k 0.8× 574 0.4× 379 0.6× 481 0.8× 437 0.9× 83 2.8k
Julien Zuber France 40 3.2k 1.8× 977 0.8× 463 0.7× 234 0.4× 706 1.4× 114 5.8k
Volker Witt Austria 21 967 0.5× 1.0k 0.8× 360 0.6× 359 0.6× 434 0.9× 61 3.4k
Konstantinos Ritis Greece 38 3.2k 1.8× 693 0.5× 808 1.3× 398 0.7× 616 1.2× 81 5.3k
N. Schleinitz France 27 1.2k 0.7× 544 0.4× 434 0.7× 230 0.4× 1.1k 2.1× 169 3.3k
Naoyuki Katayama Japan 35 1.2k 0.7× 1.1k 0.9× 441 0.7× 142 0.2× 503 1.0× 246 3.9k
S Slavin Israel 39 2.5k 1.4× 3.1k 2.4× 281 0.4× 444 0.7× 479 0.9× 186 5.7k
Francisco A. Bonilla United States 23 2.8k 1.6× 828 0.6× 747 1.2× 1.0k 1.7× 590 1.2× 33 3.5k
James Verbsky United States 28 2.9k 1.6× 630 0.5× 427 0.7× 647 1.1× 425 0.8× 81 3.8k

Countries citing papers authored by Jean‐François Viallard

Since Specialization
Citations

This map shows the geographic impact of Jean‐François Viallard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐François Viallard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐François Viallard more than expected).

Fields of papers citing papers by Jean‐François Viallard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐François Viallard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐François Viallard. The network helps show where Jean‐François Viallard may publish in the future.

Co-authorship network of co-authors of Jean‐François Viallard

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐François Viallard. A scholar is included among the top collaborators of Jean‐François Viallard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐François Viallard. Jean‐François Viallard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lambotte, O., Marion Malphettes, Louis Terriou, et al.. (2025). Pure Red Cell Aplasia Associated With Thymic Tumors, a Nationwide Retrospective Study. American Journal of Hematology. 100(12). 2230–2237.
2.
Moulis, Guillaume, Sylvain Audia, Louis Terriou, et al.. (2025). Efficacy and safety of dapsone in adult primary immune thrombocytopenia. Blood Advances. 9(8). 1976–1983.
3.
Viallard, Jean‐François, Marie Parrens, Patrick Blanco, et al.. (2024). Influence of Splenomegaly and Splenectomy on the Immune Cell Profile of Patients with Common Variable Immunodeficiency Disease. Journal of Clinical Immunology. 44(2). 46–46. 4 indexed citations
4.
Rivière, Étienne, Rodolphe Thiébaut, Estibaliz Lazaro, et al.. (2023). Assessment of circulating blood lymphocytes in adult patients on rituximab to treat immune thrombocytopenia: Circulating number of NK cells is associated with the response at 6 months. British Journal of Haematology. 202(1). 159–167. 4 indexed citations
5.
Barraco, Fiorenza, Jean‐Christophe Ianotto, Éric Jourdan, et al.. (2023). Advances in management of primary myelofibrosis and polycythaemia vera: Implications in clinical practice. SHILAP Revista de lepidopterología. 4(3). 779–791. 2 indexed citations
6.
Raymond‐Letron, Isabelle, et al.. (2023). Validation of ELISAs for Isoflavones and Enterolactone for Phytoestrogen Intake Assessment in the French Population. Nutrients. 15(4). 967–967. 5 indexed citations
7.
Bloch‐Queyrat, Coralie, Robin Dhôte, Marc Michel, et al.. (2023). HLH-JAK the First Open-Label, Phase II Study Evaluating Anti-JAK1 Itacitinib, for Non Severe HLH in Adults. Blood. 142(Supplement 1). 678–678. 1 indexed citations
8.
Donadieu, Jean, Blandine Beaupain, Jean‐François Viallard, et al.. (2022). ELANE neutropenia and solid tumors: Four cases from the French severe chronic neutropenia registry. Pediatric Blood & Cancer. 69(11). e29923–e29923.
9.
Mageau, Arthur, Louis Terriou, Mikaël Ebbo, et al.. (2021). Splenectomy for primary immune thrombocytopenia revisited in the era of thrombopoietin receptor agonists: New insights for an old treatment. American Journal of Hematology. 97(1). 10–17. 22 indexed citations
10.
Duval, Fanny, C. Greib, Estibaliz Lazaro, et al.. (2021). Myasthenia gravis and paroxysmal nocturnal hemoglobinuria after thymectomy: A rare association. SHILAP Revista de lepidopterología. 2(4). 834–837. 1 indexed citations
11.
Loizon, Séverine, et al.. (2020). Functions of Tfh Cells in Common Variable Immunodeficiency. Frontiers in Immunology. 11. 6–6. 13 indexed citations
12.
Viallard, Jean‐François, Sylvain Choquet, Bruno Royer, et al.. (2018). The use of octagam and gammanorm in immunodeficiency associated with hematological malignancies: a prospective study from 21 French hematology departments. Hematology. 24(1). 173–182. 19 indexed citations
13.
Jacquemin, C., Jean‐François Augusto, Marc Scherlinger, et al.. (2018). OX40L/OX40 axis impairs follicular and natural Treg function in human SLE. JCI Insight. 3(24). 62 indexed citations
14.
Kuter, David J., James B. Bussel, Adrian C. Newland, et al.. (2013). Long‐term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy. British Journal of Haematology. 161(3). 411–423. 203 indexed citations
15.
Lazaro, Estibaliz, et al.. (2013). Romiplostim as early treatment for refractory primary immune thrombocytopenia. International Journal of Hematology. 98(5). 520–524. 13 indexed citations
16.
Grimaldi‐Bensouda, Lamiae, Marc Michel, Jean‐François Viallard, et al.. (2011). A Multicenter Case-Control Prospective Study to Assess the Risk of Immune Thrombocytopenia (ITP) Associated with Vaccines in Adults Using the PGRx-ITP Registry. Blood. 118(21). 1169–1169. 3 indexed citations
17.
Pellegrin, Isabelle, Rodolphe Thiébaut, Patrick Blanco, et al.. (2005). Can highly active antiretroviral therapy be interrupted in patients with sustained moderate HIV RNA and > 400 CD4+ cells/µl? Impact on immunovirological parameters. Journal of Medical Virology. 77(2). 164–172. 12 indexed citations
18.
Solanilla, A., Christophe F. Grosset, Pascale Duchez, et al.. (2003). Flt3‐ligand induces adhesion of haematopoietic progenitor cells via a very late antigen (VLA)‐4‐ and VLA‐5‐dependent mechanism. British Journal of Haematology. 120(5). 782–786. 32 indexed citations
19.
Bonnet, S., P. Mercié, Jean‐François Viallard, et al.. (2001). Macro-CK révélatrice d’un carcinome épidermoïde disséminé du sinus piriforme chez un patient atteint de dermatomyosite. La Revue de Médecine Interne. 22(3). 292–296. 2 indexed citations
20.
Lacombe, Francis, Françis Belloc, Jean‐François Viallard, et al.. (1996). Drug resistance in acute myeloid leukemias. Hématologie. 2(5). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roshini S. Abraham Breakdown of academic impact, for papers by Siraj Misbah Breakdown of academic impact, for papers by Julien Zuber Breakdown of academic impact, for papers by Volker Witt Breakdown of academic impact, for papers by Konstantinos Ritis Breakdown of academic impact, for papers by N. Schleinitz Breakdown of academic impact, for papers by Naoyuki Katayama Breakdown of academic impact, for papers by S Slavin Breakdown of academic impact, for papers by Francisco A. Bonilla Breakdown of academic impact, for papers by James Verbsky
Rankless by CCL
2026